Cited by 123Biochemical effects in animalsParkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects

Carnisone Increases Efficiency of DOPA Therapy of Parkinson's Disease: A Pilot Study

Boldyrev, Alexander, Fedorova, Tatiana, Stepanova, Maria, Dobrotvorskaya, Irina, Kozlova, Eugenia, Boldanova, Natalia, Bagyeva, Gulbakhar, Ivanova-Smolenskaya, Irina +1 more·2008·Rejuvenation Research

Abstract

The addition of the neuropeptide carnosine ( β -alanyl-L-histidine) as a food additive to the basic protocol of Parkinson's disease treatment results in significant improvement of neurological symptoms, along with increase in red blood cell Cu/Zn-SOD and decrease in blood plasma protein carbonyls and lipid hydroperoxides, with no noticeable change in platelets MAO B activity. The combination of carnosine with basic therapy may be a useful way to increase efficiency of PD treatment.

Integrity signals

Registry

Crossref · 10.1089/rej.2008.0716

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Parkinson's patients with trembling manifestations taking Levodopa and dopamine-receptor agonists plus oral carnosine showed enhanced efficiency of basic therapy, manifested by restored levels of superoxide dismutase.

    “Parkinson’s patients with trembling manifestations taking basic treatment with Levodopa and dopamine-receptor agonists plus oral carnosine supplementation showed enhanced efficiency of basic therapy against PD, manifested by restored levels of superoxide dismutase, typically lowered in patients (Boldyrev et al. 2008).”

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Boldyrev, A., Fedorova, T., Stepanova, M., Dobrotvorskaya, I., Kozlova, E., Boldanova, N., Bagyeva, G., Ivanova-Smolenskaya, I., & Illarioshkin, S.
Affiliations
  • Research Center of Neurology, Russian Academy of Medical Sciences, Moscow, Russia.
  • Research Center of Neurology (RU)
  • Russian Academy of Sciences (RU)
Venue
Rejuvenation Research
Published
2008-08
Volume
11
Issue
4
Pages
821-827
ISSN
  • 1094-5458 (ISSN-L)
  • 1549-1684
  • 1557-8577
OpenAlex
W1978715967
Cited by
123
References
29
Citations by year
2026: 2 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 13 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 6 · 2016: 14 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 4
FWCI
2.03
Type
journal article
Language
en
Open access
closed
Locations
  • Rejuvenation Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Academy of Medical Sciences
  • Russian Academy of Sciences
Topics
  • Health Sciences › Medicine › Physiology › Biochemical effects in animals
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Keywords
carnosine, Parkinson's disease, combination therapy, copper-zinc superoxide dismutase, protein carbonyls, lipid hydroperoxides, oxidative stress, neuroprotection
MeSH terms
Adult, Aged, Carnosine, Dihydroxyphenylalanine, Drug Synergism, Female, Humans, Male, Middle Aged, Monoamine Oxidase, Parkinson Disease, Pilot Projects, Superoxide Dismutase, Treatment Outcome, Oxidative Stress, Protein Carbonylation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review